The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical nutrition, 2016 - Elsevier
Background & aims Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

[引用][C] The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical Nutrition, 2016 - cir.nii.ac.jp
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer
or distal cholangiocarcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical …, 2016 - clinicalnutritionjournal.com
Background & aims Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical Nutrition, 2016 - infona.pl
Patients with pancreatic cancer have a poor prognosis, are often cachectic, and frequently
demonstrate features of systemic inflammation, which may contribute to the phenomenon of …

The Impact of Sarcopenia and Myosteatosis on Outcomes of Unresectable Pancreatic Cancer or Distal 1 Cholangiocarcinoma

KE Rollins, N Tewari, A Ackner… - Clinical … - nottingham-repository.worktribe.com
Background and aims: Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.

KE Rollins, N Tewari, A Ackner, A Awwad… - 2016 - cabidigitallibrary.org
Background & aims: Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical …, 2015 - research.ed.ac.uk
BACKGROUND & AIMS: Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner… - Clinical nutrition …, 2016 - pubmed.ncbi.nlm.nih.gov
Background & aims Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.

KE Rollins, N Tewari, A Ackner, A Awwad… - Clinical Nutrition …, 2015 - europepmc.org
Methods All patients diagnosed with unresectable pancreatic cancer at Nottingham
University Hospitals NHS Trust between 2006 and 2013 were considered for the study. A …

[引用][C] The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma

KE Rollins, N Tewari, A Ackner, A Awwad… - 2016